Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Saiprasad Patil"'
Autor:
Tarini Prasad Sahoo, Chirag Desai, Shyam Agarwal, Amit Rauthan, Boman Dhabhar, Ghanshyam Biswas, Sandeep Batra, Rajat Saha, Arun Philip, Vijay Agarwal, Palanki Satya Dattatreya, PN Mohapatra, Chetan Deshmukh, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract In advanced Renal Cell Carcinoma (aRCC), systemic therapy is the mainstay of treatment, with no or little role for surgery in these patients. Tyrosine kinase inhibitors (TKIs) and immune-oncological (IOs) therapies, either alone or in combin
Externí odkaz:
https://doaj.org/article/63bb52e8c3304decb700ec7898d8f205
Autor:
Sundeep Salvi, Manish K Jain, Srikanth Krishnamurthy, Akash Balki, Rahul Kodgule, Monika Tandon, Sagar Bhagat, Sagar Panchal, Nishtha Khatri, Wen Wu, Amol Pendse, Saiprasad Patil, Hanmant Barkate
Publikováno v:
Lung India, Vol 39, Iss 6, Pp 517-524 (2022)
Background: The safety and efficacy of fixed-dose combination (FDC) of glycopyrronium bromide 12.5 μg/formoterol fumarate 12 μg (GB/FF) twice daily as dry powder inhalers (DPIs) compared to glycopyrronium 50 μg monotherapy (GLY) once daily as DPI
Externí odkaz:
https://doaj.org/article/052dbb819fae4f47a2236abea3e17974
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Chemotherapy induced nausea- vomiting (CINV) is considered as the most common, feared and most troublesome side effect of chemotherapy. NEPA (NEtupitant 300 mg + PAlonosetron 0.50 mg) is the first commercially available oral fixed
Externí odkaz:
https://doaj.org/article/bd27045ca3a24b8dbb05554950d05d0c
Autor:
Zarir F. Udwadia, Pawan Singh, Hanmant Barkate, Saiprasad Patil, Shabbir Rangwala, Amol Pendse, Jatin Kadam, Wen Wu, Cynthia F. Caracta, Monika Tandon
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 62-71 (2021)
Objective: To assess the efficacy and safety of favipiravir in adults with mild-to-moderate coronavirus disease 2019 (COVID-19). Methods: In this randomized, open-label, parallel-arm, multicenter, phase 3 trial, adults (18–75 years) with RT-PCR con
Externí odkaz:
https://doaj.org/article/4e4066fdaf884deba2ec80352ad2f675
Autor:
Shashank Joshi, Jalil Parkar, Abdul Ansari, Agam Vora, Deepak Talwar, Mangesh Tiwaskar, Saiprasad Patil, Hanmant Barkate
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 501-508 (2021)
The coronavirus disease-2019 (COVID-19) outbreak all over the world has led the researchers to strive to develop drugs or vaccines to prevent or halt the progression of this ailment. To hasten the treatment process, repurposed drugs are being evaluat
Externí odkaz:
https://doaj.org/article/2958a3f74f5443658cc11941a5674986
Autor:
Raja Dhar, Deepak Talwar, Sundeep Salvi, B.V. Muralimohan, Sagar Panchal, Saiprasad Patil, Sagar Bhagat, Nishtha Khatri, Hanmant Barkate
Publikováno v:
ERJ Open Research, Vol 8, Iss 1 (2022)
Obstructive airway disease (OAD), which includes COPD and asthma, is the leading cause of morbidity and mortality in India. Long-acting bronchodilators (long-acting β2 agonists (LABAs) and/or long-acting muscarinic antagonists (LAMAs)) and inhaled c
Externí odkaz:
https://doaj.org/article/2c05dc35cac54099bda7707b4e0e17fa
Autor:
Sundeep Salvi, Akash Balki, Srikanth Krishnamurthy, Sagar Panchal, Saiprasad Patil, Rahul Kodgule, Hitesh Khandagale, Amol Pendse, Wen Wu, Shabbir Rangwala, Monika Tandon, Hanmant Barkate
Publikováno v:
ERJ Open Research, Vol 7, Iss 3 (2021)
Background The aim of this work was to investigate the safety and efficacy of single-inhaler triple therapy with 12.5 μg glycopyrronium (GB)/12 μg formoterol fumarate (FF)/250 μg fluticasone propionate (FP), compared to 50 μg GB co-administered w
Externí odkaz:
https://doaj.org/article/75c81963141e4675813d77edae65dde4
Autor:
Ashok K. Vaid, Sudeep Gupta, Dinesh C. Doval, Shyam Agarwal, Shona Nag, Poonam Patil, Chanchal Goswami, Vikas Ostwal, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and feared side effects in cancer patients undergoing chemotherapy. Scientific evidence proves its detrimental impact on a patient's quality of life (QoL), treatment compliance
Externí odkaz:
https://doaj.org/article/c01e4fab1a6f412cb607a173ecb8b6f4
Autor:
Zarir F. Udwadia, Hanmant Barkate, Saiprasad Patil, Shabbir Rangwala, Wen Wu, Cynthia F. Caracta, Monika Tandon
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 686-687 (2021)
Externí odkaz:
https://doaj.org/article/07b88cf4d2af415abfa8f695973e93ea
Autor:
Raja Dhar, Deepak Talwar, Prince James, Ashwini Mishra, Judo Vachaparambil, Saiprasad Patil, Nishtha Khatri, Sagar Bhagat, Hanmant Barkate
Publikováno v:
Advances in Respiratory Medicine. 90:407-424
Inhaled corticosteroid and ultra-long-acting beta-agonist (ICS/uLABA) combination is a recent advancement in the armamentarium against obstructive airways diseases (OADs). The combination of ICS/uLABA has several advantages, creating a favorable land
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e147d07c28f5fe67c8aff89ba6907d07
https://doi.org/10.3390/arm90050051
https://doi.org/10.3390/arm90050051